Plasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor

scientific article published on 27 February 2019

Plasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/BIOS9010032
P932PMC publication ID6468433
P698PubMed publication ID30818887

P50authorEstefanía Nova-LampertiQ90323176
Alejandra FloresQ92015488
P2093author name stringPaola Jara
Claudio Aguayo
Liliana Lamperti
Paulina Bustos
Camila Vejar
Evelyn Poblete
Herbert Herlitz-Cifuentes
Irene Castro
Jorge Gajardo
Katia Saez
Marina Opazo
P2860cites workPredictors of endothelial dysfunction and atherosclerosis in rheumatoid arthritis in Indian population.Q54987434
Rheumatoid arthritisQ56656479
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyQ60298067
High LDL levels are associated with increased lipoprotein-associated phospholipase A2 activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cellsQ61849197
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patientsQ82852725
Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammationQ84049129
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up studyQ85249103
Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicatorsQ26864064
Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen speciesQ33778590
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thicknessQ34153114
Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritisQ34191955
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal studyQ34272487
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritisQ34401259
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesQ34889152
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritisQ35036976
Patterns of cardiovascular risk in rheumatoid arthritisQ35638493
Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritisQ35638708
Biomarkers of subclinical atherosclerosis in patients with autoimmune disordersQ35864204
Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic InflammationQ35892871
Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid ArthritisQ35979054
Inflammation and atherosclerosis in rheumatoid arthritisQ36117564
Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammationQ36276126
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosisQ36511541
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinionQ37058791
Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular riskQ37518361
State-of-the-art: rheumatoid arthritisQ37801492
Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic DiseaseQ38865647
Effect of homeostasis model assessment computational method on the definition and associations of insulin resistanceQ42939587
Peroxynitrite causes endothelial cell monolayer barrier dysfunctionQ43705436
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Q43832641
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?Q45235877
Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants.Q46304091
Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidantsQ46527152
Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patientsQ46810525
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence.Q50074049
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
reactive oxygen speciesQ424361
P304page(s)32
P577publication date2019-02-27
P1433published inBiosensorsQ27724883
P1476titlePlasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor
P478volume9

Search more.